Characterizing ligands for farnesoid X receptor – available in vitro test systems for farnesoid X receptor modulator development

Author： Merk Daniel   Steinhilber Dieter   Schubert-Zsilavecz Manfred  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.9, Iss.1, 2014-01, pp. : 27-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hologram QSAR Studies on Farnesoid X Receptor Activators

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 4, 2006-05 ,pp. : 261-267

Bentham Science Publishers

Access to resources Recommend Favorite

The farnesoid X receptor: a novel drug target?

By Claudel Thierry   Sturm Ekkehard   Kuipers Folkert   Staels Bart  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 9, 2004-09 ,pp. : 1135-1148

Informa Healthcare

Access to resources Recommend Favorite

Bile Acid Derivatives as Ligands of the Farnesoid X Receptor: Molecular Determinants for Bile Acid Binding and Receptor Modulation

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 19, 2014-10 ,pp. : 2159-2174

Bentham Science Publishers

Access to resources Recommend Favorite

Beyond Bile Acids: Targeting Farnesoid X Receptor (FXR) with Natural and Synthetic Ligands

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 19, 2014-10 ,pp. : 2129-2142

Bentham Science Publishers

Access to resources Recommend Favorite

Medicinal Chemistry and Pharmacological Effects of Farnesoid X Receptor (FXR) Antagonists

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 19, 2014-10 ,pp. : 2188-2205

Bentham Science Publishers

Access to resources Recommend Favorite